Skip to main content
logo
Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
88.07
-2.38 (-2.63%)
Jul 29, 2026, 4:00 PM EDT - Market closed

Oruka Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5,3121,82372625410372
Market Cap Growth
912.63%151.13%2844.89%-93.98%10.23%-19.08%
Enterprise Value
4,8141,491354.22-12.58367.66318.81
Last Close Price
88.0730.3119.3920.4028.4425.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
9.133.861.900.679.837.28
P/TBV Ratio
8.862.930.850.660.820.59

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
---1.73--
EV/EBIT Ratio
---1.72--
EV/FCF Ratio
---2.51--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.010.010.01
Net Debt / Equity Ratio
-0.79-0.71-0.98-1.01-1.01-1.04
Net Debt / EBITDA Ratio
2.902.75-5.113.992.74
Net Debt / FCF Ratio
4.243.79-7.433.862.82
Quick Ratio
23.3821.9228.8058.7637.5015.25
Current Ratio
23.7622.3728.8959.0137.7215.56
Return on Equity (ROE)
-24.25%-24.69%0.00%-13.57%-21.41%-39.61%
Return on Assets (ROA)
-26.87%-27.59%0.00%-18.03%-21.62%-36.71%
Return on Invested Capital (ROIC)
-112.80%-169.09%0.00%---
Return on Capital Employed (ROCE)
-27.76%-28.51%0.00%-18.43%-22.69%-39.32%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-85.49%-171.68%-1297.57%-0.04%-3.64%-195.18%
Total Shareholder Return
-85.49%-171.68%-1297.57%-0.04%-3.64%-195.18%
SEC Filings: 10-K · 10-Q